$ACST - 1.618 Extention Target Inbound

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

SHORT INTEREST
1.21M 09/30/19

P/E Current
-3.01

P/E Ratio (with extraordinary items)
-4.02

Average Recommendation: BUY

Average Target Price: 5.31